2.Self-Sufficiency in Growth Signals.

LOGIC NOTE: Self-Sufficiency in Growth Signals (Oncogenes)

Core Question

How does a normal cell that needs permission to divide become a cancer cell that divides without asking?

1. Fundamental Logic Shift

Normal cell logic

A normal cell follows this rule:

No external growth signal → no proliferation

This dependence is enforced by:

• Paracrine growth factors
• Ligand-dependent receptors
• Signal pathways that switch ON then OFF
• Nuclear transcription factors that act transiently
• Cell-cycle checkpoints with brakes (CDK inhibitors, RB, p53)

So proliferation is conditional, temporary, and reversible.

Cancer cell logic

A cancer cell rewrites the rule:

Proliferation does not require external permission

This happens because of gain-of-function mutations in proto-oncogenes, converting them into oncogenes.

Key principle:

• One mutated allele is enough
• Oncogenes act dominantly
• They generate continuous mitogenic signalling

Result:

The cell behaves as if the growth signal is permanently present, even when it is not.

🧠 EXAM REFLEX BLOCK — “Permissionless Proliferation”

Use this block to lock the concept for SBAs, EMQs, and viva answers.

🔑 Core Switch (One-Line Exam Answer)

Cancer cells divide without external growth signals because gain-of-function mutations convert proto-oncogenes into oncogenes that deliver continuous, autonomous mitogenic signalling.

⚙️ Exam-Critical Mechanism (Stepwise Reflex)

• Normal cell
• Growth factor must bind receptor
• Signal is time-limited
• Pathway switches OFF
• Cell cycle proceeds only if checkpoints allow
• Cancer cell
• Mutation mimics constant growth signal
• Pathway is constitutively active
• Signal never switches OFF
• Cell enters cell cycle without permission

🧬 Oncogene Rules — Must Recall Exactly

• Mutation type → Gain of function
• Gene affected → Proto-oncogene → Oncogene
• Allele requirement → Single allele sufficient
• Genetic behavior → Dominant
• Signalling pattern → Continuous, ligand-independent

🎯 How Examiners Phrase It (Triggers)

If the question mentions:

• “Ligand-independent signalling”
• “Constitutive activation”
• “Single allele mutation causing proliferation”
• “Autonomous growth”

👉 The answer is oncogene activation, not tumor suppressor loss.

⚠️ High-Yield Contrast Trap

🧠 Memory Lock (Exam Reflex Line)

Oncogenes don’t remove brakes — they fake the accelerator signal.

2. Normal Proliferation Pathway — Why There Are 5 Vulnerable Levels

Normal proliferation is a linear dependency chain:

1. Growth factor availability
2. Growth factor receptor activation
3. Intracellular signal transduction
4. Nuclear transcription factor activation
5. Cell-cycle machinery engagement

Logic point:

If cancer activates any ONE of these steps constitutively, the downstream steps are automatically activated.

Hence:

Cancer does not need to break all controls — one stuck accelerator is enough.

3. Growth Factors — Removing the Need for Neighbours

Normal state

• Growth factors act paracrinally
• Cells usually do not respond to their own growth factors
• This enforces tissue-level control

Cancer logic changes

A. Autocrine signalling

Tumor cell:

• Produces a growth factor
• Expresses its receptor
• Responds to itself

Result:

Growth stimulation becomes self-generated.

Examples:

• Glioblastoma → PDGF
• Sarcomas → TGF-α

B. Paracrine stromal manipulation

Tumor cell:

• Recruits fibroblasts, inflammatory cells
• Forces them to secrete mitogens (HGF, PDGF, FGF, TGF-β)
• Then uses those signals

Result:

Tumor builds its own growth-supporting microenvironment

Clinical logic:

Tumors do not need systemic hormones → they manufacture local mitogens.

4. Growth Factor Receptors — Making the Doorbell Ring Forever

Normal receptor logic

• Ligand binds
• Receptor dimerizes
• Kinase activates
• Signal propagates
• Signal stops when ligand disappears

Cancer receptor logic

Mechanism 1: Overexpression

• Gene amplification → excess receptors
• Even minimal ligand → massive signalling
• Sometimes spontaneous signalling due to clustering

Mechanism 2: Activating mutations

• Structural alteration → kinase permanently active
• Ligand not required

Result:

Receptor behaves as if ligand is always bound

Key examples:

• EGFR overexpression (lung SCC, glioblastoma, head & neck cancers)
• HER2 amplification (~20% breast cancers)

Therapeutic logic:

• Targeting the receptor can shut down the pathway (e.g. anti-HER2 therapy)

5. Signal-Transducing Proteins — Bypassing the Receptor Entirely

Normal role

These proteins are relays, not initiators.

They should only signal when the receptor tells them to.

Cancer logic

Mutations make these proteins autonomous.

Even if:

• No ligand
• No receptor activation

→ the signal continues.

6. RAS — The Prototype Accelerator Jam

Why RAS is central

• Present in many pathways
• Acts as a binary molecular switch

Normal states:

• RAS-GTP = ON
• RAS-GDP = OFF

Normal safety:

• Intrinsic GTPase activity
• GAP proteins (e.g. NF1)

Oncogenic RAS mutation logic

Mutation effects:

• GTP hydrolysis impaired
• RAS cannot turn OFF

Result:

RAS is locked in the ON position

Downstream consequences:

• MAPK pathway → proliferation
• PI3K/AKT pathway → survival + growth
• MYC activation → metabolism + cell cycle

Supporting logic:

• Loss of NF1 removes OFF switch
• Loss of PTEN removes PI3K brake

7. ABL — When a Controlled Kinase Loses Its Locks

Normal ABL

• Has inhibitory domains
• Activity tightly regulated

BCR-ABL fusion logic (CML)

Chromosomal translocation:

• Removes inhibitory regulation
• Creates constitutively active kinase

Result:

• Continuous growth signalling
• Myeloid proliferation independent of normal controls

Therapeutic logic:

• Tumor becomes addicted to one oncogene
• Blocking it (imatinib) collapses the system
• Resistance occurs when binding is prevented

8. Nuclear Transcription Factors — Final Common Pathway

Core logic

All upstream signals converge here.

If transcription factors are constitutively active, upstream control becomes irrelevant.

MYC logic

MYC:

• Drives G1 → S transition
• Upregulates CDKs
• Increases biosynthesis
• Reprograms metabolism

Genetic mechanisms:

• Translocation (Burkitt lymphoma)
• Amplification (NMYC, LMYC)

Result:

Cell is transcriptionally programmed for continuous growth

9. Cell-Cycle Machinery — Forcing the Commitment Point

Normal control

• Cyclins rise and fall
• CDKs require activation
• CDK inhibitors provide brakes
• G1/S checkpoint is decisive

Cancer logic

A. Accelerator gain

• Cyclin D / CDK4 amplification
• Excessive G1 → S progression

B. Brake loss

• CDKN2A (p16) deletion/silencing
• CDKs remain unchecked
• RB becomes hyperphosphorylated
• E2F released → DNA synthesis begins

Result:

Cell is forced past the point of no return

10. Critical Integrative Principle

Self-sufficiency in growth signals alone does NOT equal cancer.

Why?

• Excessive signalling can trigger:
• Senescence
• Apoptosis
• DNA damage responses

Therefore:

Oncogene activation must be accompanied by loss of tumor suppressors (p53, RB, etc.) for full malignant transformation.

ONE-LINE MASTER LOGIC

Cancer cells proliferate because gain-of-function oncogenic mutations convert normally conditional, transient growth signalling into autonomous, continuous, and irreversible mitogenic drive — at any level from growth factor to cell-cycle engine.

🔒 EXAM REFLEX BLOCK — Self-Sufficiency in Growth Signals (ZERO-OMISSION)

1️⃣ Core Framework (5 Vulnerable Levels)

• Normal proliferation depends on a linear 5-step dependency chain:
1. Growth factor availability
2. Growth factor receptor activation
3. Intracellular signal transduction
4. Nuclear transcription factor activation
5. Cell-cycle machinery engagement
• Exam reflex:

➜ Constitutive activation at ANY single level automatically activates all downstream steps.

➜ Cancer needs one stuck accelerator, not multiple failures.

2️⃣ Growth Factors — Loss of Neighbour Dependence

• Normal: Paracrine signalling → tissue-level control.
• Cancer mechanisms:
• Autocrine signalling: Tumour produces its own growth factor + receptor.
• Examples:
• Glioblastoma → PDGF
• Sarcomas → TGF-α
• Paracrine stromal manipulation: Tumour induces fibroblasts/inflammatory cells to secrete HGF, PDGF, FGF, TGF-β.
• Exam reflex:

➜ Tumours are hormone-independent but mitogen-dependent, and they manufacture mitogens locally.

3️⃣ Growth Factor Receptors amplification— Permanent Activation

• Normal: Ligand-dependent, transient activation.
• Cancer mechanisms:
• Overexpression (gene amplification): Minimal ligand → massive signalling.
• Activating mutations: Ligand-independent kinase activity.
• Key examples:
• EGFR overexpression → lung SCC, glioblastoma, head & neck cancers
• HER2 amplification → ~20% breast cancers
• Therapeutic reflex:

➜ Receptor blockade can collapse signalling (oncogene addiction).

4️⃣ Signal-Transducing Proteins — Receptor Bypass

• Normal: Act only as relays.
• Cancer: Mutated → signal without receptor or ligand.
• Exam reflex:

➜ Downstream activation makes upstream inhibition irrelevant.

5️⃣ RAS — Prototype “ON-Switch Jam”

• Normal:
• RAS-GTP = ON
• RAS-GDP = OFF
• Controlled by intrinsic GTPase + GAPs (NF1)
• Oncogenic mutation:
• Impaired GTP hydrolysis → permanently ON
• Downstream effects:
• MAPK → proliferation
• PI3K/AKT → survival
• MYC → metabolism + cell cycle
• Supporting losses:
• NF1 loss → OFF switch gone
• PTEN loss → PI3K brake removed

6️⃣ ABL — Constitutive Tyrosine Kinase

• Normal: Autoinhibited kinase.
• BCR-ABL fusion (CML):
• Loss of inhibitory control
• Continuous mitogenic signalling
• Therapeutic reflex:

➜ Tumour addicted to single oncogene → kinase inhibition (e.g. imatinib) causes collapse; resistance = binding alteration.

7️⃣ Nuclear Transcription Factors — Final Common Pathway

• Key principle: All upstream pathways converge here.
• MYC effects:
• Drives G1 → S transition
• ↑ CDKs
• ↑ biosynthesis
• Metabolic reprogramming
• Genetic mechanisms:
• Translocation → Burkitt lymphoma
• Amplification → N-MYC, L-MYC
• Exam reflex:

➜ Constitutive transcription factor activity makes upstream control irrelevant.

8️⃣ Cell-Cycle Machinery — Forcing Commitment

• Normal: Balanced cyclins, CDKs, inhibitors; G1/S checkpoint decisive.
• Cancer mechanisms:
• Accelerator gain: Cyclin D / CDK4 amplification
• Brake loss: CDKN2A (p16) deletion → unchecked CDKs
• End result:
• RB hyperphosphorylation
• E2F release
• Irreversible S-phase entry

9️⃣ Critical Integrative Rule (HIGH-YIELD)

• Self-sufficiency in growth signals ≠ cancer by itself
• Excess signalling can trigger:
• Senescence
• Apoptosis
• DNA damage response
• Therefore:

➜ Oncogene activation MUST be paired with tumour suppressor loss (p53, RB) for malignant transformation.

🧠 ULTIMATE EXAM ONE-LINER

Cancer proliferation results from gain-of-function oncogenic mutations that convert conditional, transient growth signalling into autonomous, continuous, irreversible mitogenic drive — at any level from growth factor to cell-cycle engine — requiring concurrent tumour suppressor loss for malignancy.

SELF-SUFFICIENCY IN GROWTH SIGNALS (ONCOGENES) — MASTER TABLE

ULTRA-SHORT EXAM MEMORY LOCK

Oncogenes fake the accelerator signal; tumour suppressors remove the brakes — both are required for cancer.